ceric oxide has been researched along with Liver Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bhave, S; Boey, A; Ho, HK; Leong, SQ | 1 |
| Godugu, C; Khurana, A; Saifi, MA | 1 |
| Carvajal, S; Casals, E; Casals, G; Fernández-Varo, G; González de la Presa, B; Jiménez, W; Oró, D; Puntes, V; Reichenbach, V; Sandalinas, S; Yudina, T | 1 |
3 other study(ies) available for ceric oxide and Liver Cirrhosis
| Article | Year |
|---|---|
Cerium Oxide Nanoparticles Alleviate Hepatic Fibrosis Phenotypes In Vitro.
Topics: Antifibrotic Agents; Antioxidants; Cell Line; Cerium; Humans; Liver; Liver Cirrhosis; Nanoparticles; Oxidative Stress | 2021 |
Rare earth cerium oxide nanoparticles attenuated liver fibrosis in bile duct ligation mice model.
Topics: Animals; Bile Ducts; Chemical and Drug Induced Liver Injury, Chronic; Liver Cirrhosis; Mice; Mice, Inbred C57BL | 2023 |
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis.
Topics: Actins; Animals; Anti-Inflammatory Agents; Apoptosis; Caspase 3; Cerium; Endoplasmic Reticulum Stress; Fatty Liver; Hypertension, Portal; Liver; Liver Cirrhosis; Nanoparticles; Rats; Reactive Oxygen Species | 2016 |